|
|
Volumn 10, Issue 8, 2013, Pages 431-
|
|
Bladder cancer: Second-line nab-paclitaxel for advanced urothelial carcinoma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBUMIN;
DOCETAXEL;
GEMCITABINE;
PACLITAXEL;
PEMETREXED;
VINFLUNINE;
ADVANCED CANCER;
BLADDER CANCER;
BREAST METASTASIS;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG TOLERANCE;
HEALTH CARE QUALITY;
HUMAN;
KIDNEY PELVIS CANCER;
METASTASIS;
NOTE;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
TRANSITIONAL CELL CARCINOMA;
UNSPECIFIED SIDE EFFECT;
URETER CANCER;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARCINOMA;
DRUG CARRIERS;
FEMALE;
HUMANS;
KIDNEY NEOPLASMS;
MALE;
NANOPARTICLES;
PACLITAXEL;
URETERAL NEOPLASMS;
URINARY BLADDER NEOPLASMS;
UROTHELIUM;
|
|
EID: 84881611803
PISSN: 17594812
EISSN: 17594820
Source Type: Journal
DOI: 10.1038/nrurol.2013.131 Document Type: Note |
|
Times cited : (2)
|
|
References (1)
|
